Citigroup’s Milestone Scientific MLSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Sell
1
-22
-96% -$6 ﹤0.01% 6214
2025
Q4
$6 Buy
+23
New +$9 ﹤0.01% 5847
2021
Q2
Sell
-3,146
Closed -$11K 6295
2021
Q1
$11K Sell
3,146
-4,958
-61% -$17K ﹤0.01% 5587
2020
Q4
$17K Buy
8,104
+6,074
+299% +$10.7K ﹤0.01% 6744
2020
Q3
$3K Sell
2,030
-2,793
-58% -$4.87K ﹤0.01% 7218
2020
Q2
$9K Buy
+4,823
New +$8.83K ﹤0.01% 7094

Other funds holding MLSS

Citigroup's MLSS Position: Q1 2026 in Review

Citigroup reduced its Milestone Scientific (MLSS) stake by 96% in Q1 2026, selling an estimated $6 and leaving 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6214.

Citigroup first reported a position in MLSS in Q2 2020 and has held it in 6 quarters since. The position peaked at $17K in Q4 2020. 32 funds tracked by Wall St. Rank hold MLSS as of Q1 2026.

  • Citigroup held 1 share of Milestone Scientific worth $0 as of Q1 2026.
  • Citigroup sold 22 Milestone Scientific shares in Q1 2026, an estimated $6.
  • Milestone Scientific made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #6214 holding.
  • Citigroup first reported a position in Milestone Scientific in Q2 2020 and has held it in 6 quarters since.
  • Citigroup's Milestone Scientific position peaked at $17K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Milestone Scientific as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.